Your session is about to expire
← Back to Search
Minds and Mentors Program for Opioid Use Disorder (MiMP Trial)
MiMP Trial Summary
This trial will test the effectiveness of the Minds and Mentors Program (MiMP) in treating individuals with opioid use disorder. The study will compare the MiMP to Twelve Step Facilitation, and will measure outcomes such as adherence to medication, rates of relapse and cravings, and self-reported anxiety, stress, and depression. Additionally, the trial will examine whether pre-intervention cortisol reactivity is predictive of relapse outcomes, and/ or whether reductions in cortisol reactivity over the course of intervention mediate relapse outcomes.
MiMP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMiMP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MiMP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have recently been thinking about hurting yourself or others.You have been using alcohol or drugs excessively and may require hospitalization or specialized treatment to help you stop using.I may have a mood or anxiety disorder but have been stable on medication for at least 2 weeks.I am 19 years old or older.I am currently on medication for opioid use disorder.I may have a mood or anxiety disorder but have been stable on medication for at least 2 weeks.I am not currently pregnant.I am willing to attend 12 therapy sessions and follow-up assessments for 9 months.I can manage my psychiatric symptoms without starting new medications.I do not have any health conditions that would make the proposed treatment unsafe for me.I have significant difficulty with my memory or thinking.You need a smartphone or computer with internet access.
- Group 1: Mindfulness based relapse prevention and peer mentoring
- Group 2: 12 Step Treatment Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are accepted in this experimental endeavor?
"Affirmative. According to the clinicaltrials.gov dataset, this medical research project is still recruiting participants - the trial was initially published on April 1st 2022 and underwent its last modification on July 25th of the same year. The initiative aims to enrol a total of 240 patients from 4 different hospitals."
Is this experiment still recruiting participants?
"Affirmative, the information found on clinicaltrials.gov implies that this study is currently enrolling participants. The research was originally announced on April 1st 2022 and has been updated as recently as July 25th 2022. This trial requires a total of 240 candidates to be recruited at 4 distinct sites."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger